• SPX
  • $5,938.50
  • 0.36 %
  • $21.39
  • DJI
  • $43,483.81
  • 0.17 %
  • $75.33
  • N225
  • $38,026.17
  • -0.85 %
  • -$326.17
  • FTSE
  • $8,121.01
  • 0.44 %
  • $35.94
  • IXIC
  • $19,053.75
  • 0.46 %
  • $87.61
Oscar Health, Inc. (OSCR) Stock Price, News & Analysis

Oscar Health, Inc. (OSCR) Stock Price, News & Analysis

Currency in USD Disclaimer

$17.10

$0.1

(0.61%)

Day's range
$16.6
Day's range
$17.16
50-day range
$13.15
Day's range
$23.79
  • Country: US
  • ISIN: US6877931096
52 wk range
$7.29
Day's range
$23.79
  • CEO: Mr. Mark Thomas Bertolini
  • Website: Visit Site


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score 0.87
  • Piotroski Score 5.00
  • Grade Overweight
  • Symbol (OSCR)
  • Company Oscar Health, Inc.
  • Price $17.10
  • Changes Percentage (0.61%)
  • Change $0.1
  • Day Low $16.60
  • Day High $17.16
  • Year High $23.79

Oscar Health, Inc. provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payor clients to engage with members and patients. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 02/05/2025
  • Fiscal Year End N/A

  • Average Stock Price Target $21.00
  • High Stock Price Target $28.00
  • Low Stock Price Target $5.00
  • Potential Upside/Downside N/A
  • Consensus Rating Strong Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$0.42
  • Trailing P/E Ratio -46
  • Forward P/E Ratio -46
  • P/E Growth -46
  • Net Income $-270,728,000

Income Statement

Quarterly

Annual

Latest News of OSCR

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Oscar Health, Inc. Frequently Asked Questions

  • What is the Oscar Health, Inc. stock price today?

    Today's price of Oscar Health, Inc. is $17.10 — it has increased by +0.61% in the past 24 hours. Watch Oscar Health, Inc. stock price performance more closely on the chart.

  • Does Oscar Health, Inc. release reports?

    Yes, you can track Oscar Health, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Oscar Health, Inc. stock forecast?

    Watch the Oscar Health, Inc. chart and read a more detailed Oscar Health, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is Oscar Health, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NYSE, exchange stock trades by Oscar Health, Inc. stock ticker.

  • How to buy Oscar Health, Inc. stocks?

    Like other stocks, OSCR shares are sold on stock exchanges such as NYSE. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Oscar Health, Inc.'s EBITDA?

    Oscar Health, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Oscar Health, Inc.’s financial statements.

  • What is the Oscar Health, Inc.'s net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is -0.0461767097, which equates to approximately -4.62%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Oscar Health, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Oscar Health, Inc.'s financials relevant news, and technical analysis. Oscar Health, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Oscar Health, Inc. stock currently indicates a “sell” signal. For more insights, review Oscar Health, Inc.’s technical analysis.

  • A revenue figure for Oscar Health, Inc. for its last quarter?

    Oscar Health, Inc. published it's last quarterly revenues at $2.42 B.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.